Skip Navigation


Carcinogenesis Advance Access originally published online on December 7, 2005
Carcinogenesis 2006 27(5):1038-1046; doi:10.1093/carcin/bgi286
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
27/5/1038    most recent
bgi286v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (31)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sengottuvelan, M.
Right arrow Articles by Nalini, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sengottuvelan, M.
Right arrow Articles by Nalini, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Chemopreventive effect of trans-resveratrol - a phytoalexin against colonic aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine induced colon carcinogenesis

Murugan Sengottuvelan, Periaswamy Viswanathan 1 and Namasivayam Nalini *

Department of Biochemistry and Biotechnology, Faculty of Science and 1 Department of Pathology, Faculty of Medicine, Rajah Muthiah Medical College, Annamalai University, Annamalainagar - 608 002, Tamilnadu, India.

* To whom correspondence should be addressed. Tel: +91 4144 238343 ext. 227; Fax: +91 4144 238343 202; Email: nalininam{at}yahoo.com

Prevention of cancer remains a primary need and new chemopreventive agents must be developed for this purpose. Towards this goal, a chemoprevention study was conducted to evaluate the activity of resveratrol (Res), a phytoalexin, as an inhibitor of colon carcinogenesis. Wistar male rats were divided into six groups, group 1 were control rats, group 2 were control rats that received Res (8 mg/kg body wt p.o. everyday), rats in groups 3–6 were treated weekly with 1,2-dimethylhydrazine (DMH, 20 mg/kg body wt, s.c. x 15 times). In addition, groups 4, 5 and 6 received Res as in group 2. Modifying effects were assessed using aberrant crypt foci (ACF) and the extent of histopathological lesions as end point markers. At the end of 30 weeks, Res markedly reduced tumor incidence, the degree of histological lesions and also the size of tumors significantly (P < 0.05) as compared with the rats treated with unsupplemented DMH. The number of ACF consisting of more than six aberrant crypts per rat was observed in group 6 (6.2 ± 1.4), group 5 (7.7 ± 1.0) and group 4 (8.2 ± 1.4) which were significantly lower than that of group 3 (22.3 ± 2.4) (P < 0.05). The most pronounced inhibition of ACF development was noted in rats fed Res for the entire period and also during the post-initiation period. Also, Res administration lowered the number of argyrophilic nucleolar organizing region-associated proteins (AgNORs) per nucleus in non-lesional colonic crypts, which reflects the cell proliferation activity. Oxidative imbalance in DMH-treatment was significantly (P < 0.01) modulated on Res supplementation as indicated by optimal concentration of thiobarbituric acid reactive substances (TBARS), superoxide dismutase (SOD), catalase (CAT) and reduced glutathione (GSH). The results of our study suggest Res to be an effective chemopreventive agent, which suppresses DMH-induced colon carcinogenesis at various stages.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Anticancer ResHome page
T.-C. HSIEH
Antiproliferative Effects of Resveratrol and the Mediating Role of Resveratrol Targeting Protein NQO2 in Androgen Receptor-positive, Hormone-non-responsive CWR22Rv1 Cells
Anticancer Res, August 1, 2009; 29(8): 3011 - 3017.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
A. Bishayee
Cancer Prevention and Treatment with Resveratrol: From Rodent Studies to Clinical Trials
Cancer Prevention Research, May 1, 2009; 2(5): 409 - 418.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
R. A. Furtado, E. P. Rodrigues, F. R. R. Araujo, W. L. Oliveira, M. A. Furtado, M. B. Castro, W. R. Cunha, and D. C. Tavares
Ursolic Acid and Oleanolic Acid Suppress Preneoplastic Lesions Induced by 1,2-Dimethylhydrazine in Rat Colon
Toxicol Pathol, June 1, 2008; 36(4): 576 - 580.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. Suh, S. Paul, X. Hao, B. Simi, H. Xiao, A. M. Rimando, and B. S. Reddy
Pterostilbene, an Active Constituent of Blueberries, Suppresses Aberrant Crypt Foci Formation in the Azoxymethane-Induced Colon Carcinogenesis Model in Rats
Clin. Cancer Res., January 1, 2007; 13(1): 350 - 355.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.